{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:17:23Z","timestamp":1782947843274,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04401-8","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:14:42Z","timestamp":1778292882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Omission of completion axillary dissection in clinically node-negative breast cancer with 1\u20132 metastatic sentinel lymph nodes"],"prefix":"10.1186","volume":"24","author":[{"given":"Weiqiang","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"4401_CR1","first-page":"70","volume":"39","author":"M Anita","year":"2025","unstructured":"Anita M, Andrea VB. Updates in Surgical Management of the Axilla. ONCOLOGY-NY. 2025;39:70\u20135.","journal-title":"ONCOLOGY-NY"},{"key":"4401_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.hoc.2022.08.005","volume":"37","author":"A Laws","year":"2023","unstructured":"Laws A, Kantor O, King TA. Surgical Management of the Axilla for Breast Cancer. HEMATOL ONCOL CLIN N. 2023;37:51\u201377.","journal-title":"HEMATOL ONCOL CLIN N"},{"key":"4401_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1200\/JCO-25-00099","volume":"43","author":"KU Park","year":"2025","unstructured":"Park KU, Somerfield MR, Anne N, et al. Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update. J CLIN ONCOL. 2025;43:1720\u201341.","journal-title":"J CLIN ONCOL"},{"key":"4401_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10549-024-07310-0","volume":"206","author":"SK Yadav","year":"2024","unstructured":"Yadav SK, Bharath S, Sharma D, et al. A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer. BREAST CANCER RES TR. 2024;206:19\u201330.","journal-title":"BREAST CANCER RES TR"},{"key":"4401_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12893-023-02101-8","volume":"23","author":"YJ Fan","year":"2023","unstructured":"Fan YJ, Li JC, Zhu DM, et al. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis. BMC SURG. 2023;23:209.","journal-title":"BMC SURG"},{"key":"4401_CR6","first-page":"CD4561","volume":"1","author":"N Bromham","year":"2017","unstructured":"Bromham N, Schmidt-Hansen M, Astin M, Hasler E, Reed MW. Axillary treatment for operable primary breast cancer. COCHRANE DB SYST REV. 2017;1:CD4561.","journal-title":"COCHRANE DB SYST REV"},{"key":"4401_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. ANN SURG. 2010;252:426\u201332.","journal-title":"ANN SURG"},{"key":"4401_CR8","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","volume":"19","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23\u2009\u2013\u200901): 10-year follow-up of a randomised, controlled phase 3 trial. LANCET ONCOL. 2018;19:1385\u201393.","journal-title":"LANCET ONCOL"},{"key":"4401_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. LANCET ONCOL. 2014;15:1303\u201310.","journal-title":"LANCET ONCOL"},{"key":"4401_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","volume":"390","author":"J de Boniface","year":"2024","unstructured":"de Boniface J, Filtenborg TT, Ryd\u00e9n L, et al. Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases. NEW ENGL J MED. 2024;390:1163\u201375.","journal-title":"NEW ENGL J MED"},{"key":"4401_CR11","doi-asserted-by":"publisher","first-page":"e1473","DOI":"10.1634\/theoncologist.2020-0001","volume":"25","author":"B Yang","year":"2020","unstructured":"Yang B, Ren G, Song E, et al. Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals. ONCOLOGIST. 2020;25:e1473\u201380.","journal-title":"ONCOLOGIST"},{"key":"4401_CR12","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejca.2022.10.026","volume":"178","author":"K Cocks","year":"2023","unstructured":"Cocks K, Wells JR, Johnson C, et al. Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. EUR J CANCER. 2023;178:128\u201338.","journal-title":"EUR J CANCER"},{"key":"4401_CR13","doi-asserted-by":"publisher","first-page":"104453","DOI":"10.1016\/j.breast.2025.104453","volume":"81","author":"A Mattar","year":"2025","unstructured":"Mattar A, Antonini M, Cavalcante FP, et al. CADONOT: Comparing axillary dissection or not in breast cancer surgery. Breast. 2025;81:104453.","journal-title":"Breast"},{"key":"4401_CR14","doi-asserted-by":"crossref","unstructured":"Xie J, Wan T, Hao J et al. Can axillary lymph node dissection be omitted in breast cancer patients with 1\u20132 positive sentinel nodes? A systematic review and meta-analysis. ONCOLOGIST 2025; 30.","DOI":"10.1093\/oncolo\/oyaf379"},{"key":"4401_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12885-021-07895-5","volume":"21","author":"J Liu","year":"2021","unstructured":"Liu J, Zheng X, Han Z, Lin S, Han H, Xu C. Clinical characteristics and overall survival prognostic nomogram for invasive cribriform carcinoma of breast: a SEER population-based analysis. BMC Cancer. 2021;21:168.","journal-title":"BMC Cancer"},{"key":"4401_CR16","doi-asserted-by":"publisher","first-page":"h4901","DOI":"10.1136\/bmj.h4901","volume":"351","author":"S Saadatmand","year":"2015","unstructured":"Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM. Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ-BRIT MED J. 2015;351:h4901.","journal-title":"BMJ-BRIT MED J"},{"key":"4401_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11864-024-01258-5","volume":"25","author":"E Hsu","year":"2024","unstructured":"Hsu E, Arezo SM, Graff SL. Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast Cancer. CURR TREAT OPTION ON. 2024;25:1323\u201334.","journal-title":"CURR TREAT OPTION ON"},{"key":"4401_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1803164","volume":"379","author":"PA Francis","year":"2018","unstructured":"Francis PA, Pagani O, Fleming GF, et al. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. NEW ENGL J MED. 2018;379:122\u201337.","journal-title":"NEW ENGL J MED"},{"key":"4401_CR19","first-page":"838","volume":"21","author":"J Li","year":"2024","unstructured":"Li J, Jiang Z. Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China. CANCER BIOL MED. 2024;21:838\u201343.","journal-title":"CANCER BIOL MED"},{"key":"4401_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. NEW ENGL J MED. 2001;344:783\u201392.","journal-title":"NEW ENGL J MED"},{"key":"4401_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/bjs\/znad215","volume":"110","author":"C Tinterri","year":"2023","unstructured":"Tinterri C, Canavese G, Gatzemeier W, et al. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment. BRIT J SURG. 2023;110:1143\u201352.","journal-title":"BRIT J SURG"},{"key":"4401_CR22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.4143\/crt.2018.438","volume":"51","author":"JH Joo","year":"2019","unstructured":"Joo JH, Kim SS, Son BH, et al. Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1\u20133 Positive Nodes. CANCER RES TREAT. 2019;51:1011\u201321.","journal-title":"CANCER RES TREAT"},{"key":"4401_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.23736\/S2724-5691.24.10485-6","volume":"79","author":"D Gentile","year":"2024","unstructured":"Gentile D, Tinterri C. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy. MINERVA SURG. 2024;79:545\u201357.","journal-title":"MINERVA SURG"},{"key":"4401_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/tbj.12276","volume":"20","author":"GM Freedman","year":"2014","unstructured":"Freedman GM, Fowble BL, Li T, et al. Risk of positive nonsentinel nodes in women with 1\u20132 positive sentinel nodes related to age and molecular subtype approximated by receptor status. BREAST J. 2014;20:358\u201363.","journal-title":"BREAST J"},{"key":"4401_CR25","doi-asserted-by":"crossref","unstructured":"Pantiora E, Eriksson S, W\u00e4rnberg F, Karakatsanis A. Magnetically guided surgery after primary systemic therapy for breast cancer: implications for enhanced axillary mapping. BRIT J SURG 2024; 111.","DOI":"10.1093\/bjs\/znae008"},{"key":"4401_CR26","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.amjsurg.2007.08.024","volume":"194","author":"AB Chagpar","year":"2007","unstructured":"Chagpar AB, Carlson DJ, Laidley AL, et al. Factors influencing the number of sentinel lymph nodes identified in patients with breast cancer. AM J SURG. 2007;194:860\u20134.","journal-title":"AM J SURG"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04401-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04401-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04401-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:29:32Z","timestamp":1782944972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04401-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4401"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04401-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Henan University of science and technology (No. K-2025-1682).Written informed consent was obtained upon the final follow-up.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}